Exelixis
(NASDAQ) EXEL
Exelixis Financials at a Glance
Market Cap
$14.20BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
$2.38B
Net Income (TTM)
$833.42M
EPS (TTM)
$3.02
P/E Ratio
18.73
Dividend
$0.00
Beta (Volatility)
0.62 (Low)
Dividend
$0.00
Beta (Volatility)
0.62 (Low)
Price
$56.50
Volume
301
Open
$57.31
Price
$56.50
Volume
301
Open
$57.31
Previous Close
$56.50
Daily Range
$55.69 - $57.31
52-Week Range
$33.76 - $57.57
Estimated Earnings Date
Aug 4, 2026
Dividend
$0.00
Beta (Volatility)
0.62 (Low)
Price
$56.50
Volume
301
Open
$57.31
Previous Close
$56.50
Daily Range
$55.69 - $57.31
52-Week Range
$33.76 - $57.57
Estimated Earnings Date
Aug 4, 2026
EXEL News
EXEL: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Exelixis
Industry
Biotechnology
Sector
Health CareEmployees
1,077
CEO
Michael M. Morrissey, PhD
Website
www.exelixis.comHeadquarters
Alameda, CA 94502, US
EXEL Financials
Key Financial Metrics (TTM)
Gross Margin
96.44%
Operating Margin
39.43%
Net Income Margin
35.08%
Return on Equity
40.21%
Return on Capital
37.36%
Return on Assets
32.13%
Earnings Yield
5.34%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$14.20BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
251.35M
Volume
301
Avg. Volume
2.73M
Financials (TTM)
Gross Profit
$2.29B
Operating Income
$936.67M
EBITDA
$1.02B
Operating Cash Flow
$924.68M
Capital Expenditure
-$8.26M
Free Cash Flow
$916.41M
Cash & ST Invst.
$777.21M
Total Debt
$169.54M
Exelixis Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$610.81M
+10.0%
Gross Profit
$590.86M
+10.2%
Gross Margin
96.73%
N/A
Market Cap
$14.20BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$12.38M
N/A
Employees
1,147
N/A
Net Income
$210.47M
+31.9%
EBITDA
$274.64M
+28.9%
Quarterly Fundamentals
Total Cash
$777.21M
-24.6%
Total Debt
$169.54M
-9.4%
Accounts Receivable
$328.95M
+16.8%
Inventory
$26.61M
+7.0%
Long Term Debt
$169.54M
-9.4%
Short Term Debt
$0.00
N/A
Return on Assets
32.13%
N/A
Return on Invested Capital
42.14%
N/A
Free Cash Flow
$249.81M
+32.2%
Operating Cash Flow
$251.85M
+19.1%